In this report, LP Information covers the current scenario (with the base year being 2017) and growth prospects of the global Mitomycin C market for 2018-2023.
In the mitomycin C market, mitomycin C is an antibiotic that acts as an alkylating agent for double-stranded DNA. Covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation. It acts via reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).
In recent years, the global market for mitomycin C experienced a rapidly upward trend, with an average growth rate of 4.76%. In 2016, global revenue for mitomycin C was nearly $119.83 million; actual production is approximately 17370 K Unit.
The world average price of mitomycin C is on an increasing trend, from USD 6.30/Unit in 2012 to USD 6.90/Unit in 2016. With the world economy situation, the prices will have an increasing trend in the next five years.
The classification of mitomycin C includes 2 Mg, 10 Mg, 40 Mg, and others. The proportion of 2 Mg in 2016 is around 41.5%, and the proportion is in decreasing trend from 2012 to 2016.
Mitomycin C is widely used in cancer treatment, ophthalmic use and other fields. The largest proportion of mitomycin C is cancer treatment, and the proportion in 2016 is 69%. The trend of cancer treatment is downward.
Japan is the largest supplier of Mitomycin C, with a production market share of almost 26.5% in 2016. India is the second largest supplier of Mitomycin C Media, with a production market share of almost 25% in 2016.
North America is the largest consumption location with a consumer market share of almost 36% in 2016. After North America, Europe is the second largest consumption location with a consumer market share of 32 .6%.
Over the next five years, LPI (LP Information) projects that Mitomycin C will post a CAGR of -2.3% in terms of revenue, reaching $100 million by 2023, from $120 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of the Mitomycin C market by product type, application, key manufacturers, and key regions.
To calculate the market size, LP Information considers the value and volume generated by the sales of the following segments:
Segmentation by type of product:
2mg
10mg
40mg
other
Segmentation by application:
cancer treatment
ophthalmic use
others
This report also splits the market by region:
Americas
USA
Canada
Mexico City
Brazil
APAC
Porcelain
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
United Kingdom
Italy
Russia
Spain
Ask here and check the discount for report@:
https://www.reporthive.com/enquiry.php?id=1565680&req_type=disc
The report also presents the market competition landscape and a corresponding detailed analysis of the top vendors/manufacturers in the market. The main manufacturers covered in this report:
kyowa kirin
Intas Pharmaceuticals
it accommodates you
Bristol-Myers Squibb
Aspen
Specialized European Pharmaceutical
Alkem Laboratories
Varipharma
APOGEFA
Furthermore, this report analyzes the key drivers influencing the growth of the market, the opportunities, challenges, and risks faced by the key manufacturers and the market as a whole. It also analyzes the main emerging trends and their impact on present and future development.
Investigate Objectives:
To study and analyze the global Mitomycin C consumption (value and volume) by key regions/countries, product type and application, historical data from 2013 to 2017, and forecast to 2023.
To understand the structure of the Mitomycin C market by identifying its various subsegments.
Focuses on the key global Mitomycin C manufacturers, to define, describe, and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years. years.
To analyze the Mitomycin C with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Mitomycin C submarkets, with respect to key regions (along with their respective key countries).
Analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
Strategically profile key players and thoroughly analyze their growth strategies.
Read the full study from the research report@: https://www.reporthive.com/enquiry.php?id=1565680&req_type=purch
Table of Contents:
Chapter One: Scope of the Report
Chapter Two: Executive Summary
Chapter Three: Global Mitomycin C by Players
Chapter Four: Mitomycin C by Regions
Chapter Five: Americas
Chapter Six: APAC
Chapter Seven: Europe
Chapter Eight: Middle East and Africa
Chapter Nine: Market Drivers, Challenges and Trends
Chapter Ten: Marketing, Distributors and Customers
Read more…
List of tables and figures:
Figure Mitomycin C Consumed in Cancer Treatment
Figure Global Mitomycin C Market: Cancer Treatment (2013-2018) (K Units)
Figure Global Market for Mitomycin C: Cancer Treatment (2013-2018) (USD Million)
Figure Year-over-year global growth in cancer treatment (USD million)
Figure Mitomycin C Consumed in Ophthalmic Use
Figure Global Mitomycin C Market: Ophthalmic Use (2013-2018) (K Units)
Figure Global Mitomycin C Market: Ophthalmic Use (2013-2018) (USD Million)
Calculate the global year-on-year growth in ophthalmic use (millions of dollars) and learn more…
